oncology
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
A webinar sponsored by AVIA Health and SeamlessMD will discuss the latest trends in remote monitoring and how to extend these benefits beyond chronic conditions all while using fewer staff resources.
-
Why OneOncology Is Adopting Verily’s Clinical Trial Management System
OneOncology recently announced that it is deploying Verily’s clinical trial management platform across 11 of its community oncology clinics. Adopting Verily’s software will hopefully make clinical trial management much easier for OneOncology, which would allow the company to further democratize trials to improve health equity, the company’s chief medical officer said.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedCity Influencers, Payers, Physicians
Cancer Moonshot: Would It Even Be Possible in Today’s Fee-For-Service World?
CMS’ Enhancing Oncology Model and Cancer Moonshot are the forcing functions to achieve value-based care in oncology. In the spirit of working together to improve lives, this is a MUST for physicians to consider–before they get left behind.
-
VC Identifies 3 Startups That Will Shake Up the Future of Cancer Care
Oncology Ventures recently announced investments in three cancer startups — VivorCare, Gabbi and Health Universe. The fund’s founding partner said each company demonstrated an ability to tackle a specific problem within the cancer care space, such as enabling earlier breast cancer diagnoses and providing personalized care plans for cancer survivors.
-
MedCity Influencers, BioPharma
What A Nobel Prize-Winner’s Research Means for Cancer Treatment
Drs. Carolyn Bertozzi, Barry Sharpless, and Morten Meldal shared the 2022 Nobel Prize in Chemistry for greatly simplifying the synthesis of complicated molecules. Dr. Bertozzi’s protégé writes why her research is so important.
-
Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance
Avenda Health, a startup focused on personalized prostate cancer care, recently received 510(k) clearance from the FDA for its cancer mapping platform. The platform uses a patient’s own diagnostic data to define the extent of the disease and create a cancer probability map with optimal treatment margins.
-
MedCity Influencers, BioPharma, Health Tech
Digital Health in Oncology – Emerging Opportunities Across the Cancer Patient Journey
Cancer is a serious public health issue, accounting for nearly 10 million deaths and over […]
-
The cancer death rate is falling — focusing on equity and personalization will help it drop further
Fewer people are dying from cancer due to advances in research, screening and treatment, according to a new report. In order for the death rate to fall further, U.S. oncologists must prioritize personalized treatment and addressing social determinants of health, an expert argued.
-
Devices & Diagnostics, Health Tech, Hospitals, SYN
Strata, UW Health team up to bring genomic testing to more cancer patients
Strata Oncology partnered with UW Health to integrated its next generation sequencing tumor profiling test into the health system’s Epic EHR. Being able to order the test and see its results from within the EHR will help UW clinicians more efficiently leverage genomic findings into their precision oncology treatment plans.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Epic introduces genomic test ordering tool within EHR with Ochsner as first user
Ochsner Health added a tool to its Epic EHR that allows physicians to seamlessly order genomics tests and view results within the EHR. The integration will allow physicians to provide more personalized and effective care now that they can have a single view of their patients’ genomic and clinical data in one place. The news comes two months after MU Health Care added a similar tool into its Oracle Cerner EHR.
-
Biopharma has a brand new target: Cancer-specific collagen
Researchers at the University of Texas MD Anderson Cancer Center published a new study revealing that cancer cells make their own unique form of collagen to help them grown and proliferate. This means drug developers may have a new, highly specific target for oncology therapeutics.
-
Cancer care poses challenges for employers; Transcarent shares vision for how it can help
As they seek to support their staff, self-insured employers are turning to innovative programs to balance evidence-based programs with the need to manage healthcare costs.
-
Judges: Joint winners at INVEST Pitch Perfect’s RPM track address large unmet need, have clear reimbursement path
San Francisco-based Blumio and Saint Paul, Minnesota-based NxGenPort tied for the top prize in the Remote Patient Monitoring and Smart Devices track of INVEST Pitch Perfect, the startup competition integral to MedCity News’ INVEST conference. Here is an in-depth look at each company.
-
Precision oncology startup AnHeart Therapeutics co-founder shares cancer drug strategy
AnHeart Therapeutics is developing a pipeline of precision oncology therapeutics. Chief Business Officer and Co-founder Lihua Zheng provided an overview of company’s strategy in response to emailed questions.
-
Pillar Biosciences seeks to make precision medicine a first-line therapy for cancer patients
Randy Pritchard, Pillar Biosciences CEO, highlighted some of the progress the oncology solutions company has made in developing in-vitro diagnostics in response to emailed questions from MedCity News.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
